Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DAVID J MOONEY

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1831350198
CMS profile
1212878
Location
BIRMINGHAM, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$37,254.62

264 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $31,325.00 3
Food and Beverage $5,605.63 258
Travel and Lodging $323.99 3

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
OnMark, Inc. $32,464.84 19
Novartis Pharmaceuticals Corporation $470.71 28
PFIZER INC. $464.35 24
Celgene Corporation $325.07 17
US Oncology Corporate, Inc. $243.65 3
ABBVIE INC. $240.17 16
Janssen Biotech, Inc. $203.55 10
Eisai Inc. $201.19 10
Genentech USA, Inc. $190.51 9
E.R. Squibb & Sons, L.L.C. $182.63 15
Incyte Corporation $171.84 8
Takeda Pharmaceuticals U.S.A., Inc. $156.61 8
Lilly USA, LLC $149.04 9
Stemline Therapeutics Inc. $123.27 6
Astellas Pharma US Inc $123.04 6
Alexion Pharmaceuticals, Inc. $114.30 5
AstraZeneca Pharmaceuticals LP $111.47 6
Daiichi Sankyo Inc. $99.16 5
GlaxoSmithKline, LLC. $96.19 5
Deciphera Pharmaceuticals Inc. $85.85 4
Merck Sharp & Dohme LLC $85.39 5
PUMA BIOTECHNOLOGY, INC. $78.61 4
SOBI, INC $77.29 4
BeiGene USA, Inc. $77.21 4
Tempus AI, Inc $74.65 3
GENZYME CORPORATION $68.52 3
Ipsen Biopharmaceuticals, Inc $66.79 3
Gilead Sciences, Inc. $61.32 3
Sumitomo Pharma America, Inc. $56.83 3
Regeneron Healthcare Solutions, Inc. $52.51 3
Blueprint Medicines Corporation $50.44 2
Bayer Healthcare Pharmaceuticals Inc. $46.16 2
JAZZ PHARMACEUTICALS INC. $28.98 1
Myriad Genetic Laboratories, Inc. $24.63 1
Agios Pharmaceuticals, Inc. $23.49 1
Rigel Pharmaceuticals, Inc. $23.25 1
ADC Therapeutics America, Inc. $20.95 1
SERVIER PHARMACEUTICALS LLC $20.13 1
TAIHO ONCOLOGY, INC. $18.77 1
Adaptive Biotechnologies Corporation $18.38 1
Exelixis Inc. $17.48 1
ARRAY BIOPHARMA INC $15.36 1
Karyopharm Therapeutics Inc. $15.13 1
Apellis Pharmaceuticals, Inc. $14.91 1

Page 4 of 6; records 151–200 of 264 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DAVID J MOONEY

NPI 1831350198 · CMS profile ID 1212878

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

BIRMINGHAM, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 6; records 151–200 of 264 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1831350198?year=2024&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DAVID J MOONEY, NPI 1831350198, CMS profile ID 1212878. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 6; records 151–200 of 264 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1831350198?year=2024&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). DAVID J MOONEY, NPI 1831350198, CMS profile ID 1212878. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 6; records 151–200 of 264 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1831350198?year=2024&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
DAVID J MOONEY, NPI 1831350198, CMS profile ID 1212878, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 6; records 151–200 of 264 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1831350198?year=2024&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

264 matching records · $37,254.62 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 264 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 264.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Incyte Corporation $21.4106/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141305999 CMS
Celgene Corporation $22.5006/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101140704 CMS
Lilly USA, LLC $17.2006/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136154360 CMS
Novartis Pharmaceuticals Corporation $15.7605/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087027158 CMS
ABBVIE INC. $13.9205/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105059114 CMS
US Oncology Corporate, Inc. $55.2705/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1084863716 CMS
ABBVIE INC. $15.2105/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105059112 CMS
Lilly USA, LLC $19.6505/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136157207 CMS
ABBVIE INC. $15.1205/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105059110 CMS
Novartis Pharmaceuticals Corporation $11.2005/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087027152 CMS
Novartis Pharmaceuticals Corporation $18.7105/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087027156 CMS
PFIZER INC. $22.5905/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131330325 CMS
AstraZeneca Pharmaceuticals LP $16.3105/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104433609 CMS
Daiichi Sankyo Inc. $13.1005/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089458962 CMS
Novartis Pharmaceuticals Corporation $23.5305/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087027150 CMS
Astellas Pharma US Inc $19.1505/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139356951 CMS
Daiichi Sankyo Inc. $21.6705/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089458964 CMS
PFIZER INC. $21.4605/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131330329 CMS
E.R. Squibb & Sons, L.L.C. $16.2805/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101449380 CMS
Incyte Corporation $20.0205/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141263679 CMS
PFIZER INC. $16.6505/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131404148 CMS
PUMA BIOTECHNOLOGY, INC. $19.5105/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1113857672 CMS
AstraZeneca Pharmaceuticals LP $20.6604/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105361475 CMS
Novartis Pharmaceuticals Corporation $22.4004/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087027138 CMS
Deciphera Pharmaceuticals Inc. $24.3604/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145874289 CMS
Novartis Pharmaceuticals Corporation $9.2604/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087027142 CMS
Celgene Corporation $13.0504/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101140692 CMS
Novartis Pharmaceuticals Corporation $26.6804/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087027130 CMS
PFIZER INC. $17.2004/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131306101 CMS
Alexion Pharmaceuticals, Inc. $29.6004/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094034391 CMS
E.R. Squibb & Sons, L.L.C. $17.7404/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101449365 CMS
PFIZER INC. $22.6504/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131245463 CMS
Apellis Pharmaceuticals, Inc. $14.9104/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154019716 CMS
Incyte Corporation $17.6004/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141229387 CMS
Eisai Inc. $21.1904/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110740341 CMS
Genentech USA, Inc. $23.7504/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132998194 CMS
Takeda Pharmaceuticals U.S.A., Inc. $11.4204/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144963404 CMS
Eisai Inc. $17.4504/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110740335 CMS
Alexion Pharmaceuticals, Inc. $17.6004/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094036825 CMS
Novartis Pharmaceuticals Corporation $13.1004/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087027112 CMS
Tempus AI, Inc $26.5204/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150170172 CMS
ABBVIE INC. $22.6104/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105059108 CMS
Stemline Therapeutics Inc. $28.6304/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1142959300 CMS
ABBVIE INC. $12.6503/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105059106 CMS
Novartis Pharmaceuticals Corporation $21.2403/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087027120 CMS
SOBI, INC $24.5603/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141418988 CMS
Novartis Pharmaceuticals Corporation $12.4503/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087027118 CMS
Novartis Pharmaceuticals Corporation $10.6603/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087027114 CMS
Ipsen Biopharmaceuticals, Inc $24.1503/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1091962411 CMS
Eisai Inc. $21.5603/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110740331 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $4,449.32 267
PY2020 $6,256.69 181
PY2021 $4,607.23 223
PY2022 $7,218.75 284
PY2023 $14,820.01 240
PY2024 $37,254.62 264
PY2025 $45,621.49 259

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $287,999.25 3
PY2024 Principal investigator $673,792.45 1
PY2023 Principal investigator $533,044.15 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Celgene Corporation $16,200.00 10/29/2025 Non-covered Recipient Entity
Central Alabama Research
A Phase 3, Two-part, Randomized, Open-label, Adaptive Study Comparing BMS-986365 versus Investigators Choice of Therapy Comprising Either Docetaxel or Second Androgen Receptor Pathway Inhibitor (ARPI), in Participants with Metastatic Castration-resistant Prostate Cancer (mCRPC) - rechARge No dispute reported 06/30/2026 1222306130
Principal investigator 1 Novartis Pharmaceuticals Corporation $43,271.85 10/28/2025 Non-covered Recipient Entity
HEMATOLOGY AND ONCOLOGY ASSOCIATES OF ALABAMA, LLC
A Phase IIIb Study to Characterize the Effectiveness and Safety of Adjuvant Ribociclib in a Wide Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER) No dispute reported 06/30/2026 1190301279
Principal investigator 1 AstraZeneca UK Limited $228,527.40 01/13/2025 Non-covered Recipient Entity
CENTRAL ALABAMA RESEARCH
A Phase I-III Randomized Double blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156-AZD3152 for Pre exposure Prophylaxis of COVID 19 in Participants with Conditions Causing Immune Impairment No dispute reported 06/30/2026 1185556025